Borderline ovarian tumors: Key points and workshop summary

Steven G. Silverberg, Debra A. Bell, Robert J. Kurman, Jeffrey D. Seidman, Jaime Prat, Brigitte M. Ronnett, Larry Copeland, Elvio Silva, Fred Gorstein, Robert H. Young

Research output: Contribution to journalArticlepeer-review

Abstract

This article documents major points of agreement and disagreement among experts invited to participate in a Borderline Ovarian Tumor Workshop held in Bethesda, MD, on August 27-28, 2003. It is suggested that controversies related to the diagnosis and management of these tumors are often related to lack of data in the literature (small numbers of cases, unreported or unclear criteria for diagnosis and follow-up, insufficient length of follow-up, etc), and specific recommendations are made for further investigation and for reporting of data in future studies.

Original languageEnglish (US)
Pages (from-to)910-917
Number of pages8
JournalHuman pathology
Volume35
Issue number8
DOIs
StatePublished - Aug 2004

Keywords

  • BOT
  • M-BOT
  • PMP
  • S-BOT
  • WHO
  • World Health Organization
  • atypical proliferative
  • borderline ovarian tumor
  • borderline tumor
  • low malignant potential
  • mucinous
  • mucinous borderline ovarian tumor
  • ovary
  • pseudomyxoma peritonei
  • serous
  • serous borderline ovarian tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Borderline ovarian tumors: Key points and workshop summary'. Together they form a unique fingerprint.

Cite this